Mass Tort Leads for Personal Injury Firms
Pre-qualified, exclusive mass tort leads screened against your case criteria and delivered via our intake operation — priced on signed retainers, not clicks. Response in under 5 minutes during business hours.
Comparing sources? See how a mass tort marketing agency for law firms differs from a lead vendor, or review the best mass tort marketing agencies for 2026.
- 30+ PI firms served
- 16+ active MDLs
- 400K+ claimants screened
Updated October 13, 2026
Which active mass torts are agencies targeting right now?
These are the mass tort litigations drawing the most plaintiff advertising in late 2026, with their MDL number, court, and stage. Stage matters as much as the tort: a docket heading into settlement needs claimants signed before the deadline, while a docket waiting on an expert ruling carries more risk per signed case.
| Litigation | MDL / proceeding | Court | Stage |
|---|---|---|---|
| Depo-Provera (meningioma) | MDL 3140 | N.D. Fla. | Global settlement in principle announced June 2026; claims process forming. |
| Hair relaxer | MDL 3060 | N.D. Ill. | Expert (Rule 702) and summary judgment briefing set for December 2026; trials expected 2027. |
| AFFF firefighting foam | MDL 2873 | D.S.C. | Water-provider settlements paid; personal injury claims still being litigated. |
| Social media youth harm | MDL 3047 | N.D. Cal. | First school-district bellwether settled in 2026; further bellwethers scheduled for 2027. |
| Bard PowerPort | MDL 3081 | D. Ariz. | Bellwether trials under way in 2026, including a reported plaintiff verdict in September. |
| Suboxone film (tooth decay) | MDL 3092 | N.D. Ohio | Discovery stage; trials not expected before 2028. |
| GLP-1 / Ozempic (gastroparesis) | MDL 3094 | E.D. Pa. | Rule 702 expert ruling pending after a September 2026 hearing. |
| NEC baby formula | MDL 3026 | N.D. Ill. | Defendant won the first federal bellwethers on summary judgment; case acceptance has narrowed. |
| Talcum powder (J&J) | MDL 2738 | D.N.J. | Proposed ovarian cancer settlement announced July 2026, subject to claimant participation. |
| Bard hernia mesh | MDL 2846 | S.D. Ohio | Settlement process expected to begin in early 2027. |
| Paraquat | MDL 3004 | S.D. Ill. | Settlement program approved in 2026; opt-out claims continue. |
| Roundup | MDL 2741 | N.D. Cal. | June 2026 U.S. Supreme Court ruling on federal preemption of label claims narrows new filings. |
| Tylenol (acetaminophen) autism | MDL 3043 | S.D.N.Y. | Second Circuit revived the litigation in July 2026; cases returned to the district court. |
| Zantac | MDL 2924 | S.D. Fla. | Federal cases dismissed; Eleventh Circuit appeal pending. |
| Camp Lejeune | Camp Lejeune Justice Act | E.D.N.C. | Not an MDL; first trials scheduled late 2026 while the court pushes for a global resolution. |
Stages summarize public court reporting as of October 13, 2026 and change often. Confirm current status on the court docket or the JPML pending-MDL report before opening intake. For how stage affects acquisition cost, see mass tort marketing costs and our mass tort advertising landscape.
Active Mass Tort Campaigns
We generate qualified claimants across the most active mass tort categories in the country. Select a tort type to learn more about our campaigns and lead quality.
Camp Lejeune
Water contamination claims for veterans and families stationed at Camp Lejeune.
AFFF
Firefighting foam exposure linked to cancer and serious health conditions.
Roundup
Weedkiller exposure claims for non-Hodgkin lymphoma and related cancers.
Ozempic
GLP-1 receptor agonist claims for gastroparesis and severe digestive injuries.
NEC
Baby formula claims for necrotizing enterocolitis in premature infants.
Depo Provera
Contraceptive injection claims linked to meningioma brain tumors.
PFAS
Forever chemical contamination claims from drinking water and consumer products.
Suboxone
Sublingual film claims for severe dental decay and tooth loss.
Bard PowerPort
Implantable port catheter claims for device fracture and migration injuries.
Hair Relaxer
Chemical hair straightener claims linked to uterine cancer and fibroids.
Oxbryta
Sickle cell disease drug claims following market withdrawal for safety concerns.
Hernia Mesh
Surgical mesh implant claims for chronic pain, infection, and mesh failure.
Zantac
Heartburn medication claims for cancer caused by NDMA contamination.
Dacthal
Pesticide exposure claims linked to thyroid damage and developmental harm.
Rideshare
Assault and safety claims against rideshare companies for passenger injuries.
Risperdal
Antipsychotic medication claims for gynecomastia and hormonal side effects.
Olympus Scope
Duodenoscope and endoscope infection claims including CRE superbug outbreaks and the 2025 MAJ-891 recall.
Social Media Addiction
MDL 3047 claims against Meta, TikTok, Snap, YouTube, and Discord for adolescent mental health harms — bellwether trials approaching.
Sports Betting Addiction
Consumer protection claims against DraftKings, FanDuel, BetMGM, Caesars — predatory VIP targeting and self-exclusion failures.
Video Game Addiction
Roblox, Fortnite, and loot-box claims — variable-reinforcement design defects and unauthorized child microtransactions.
Benzene Exposure
Occupational and consumer-product benzene claims — AML, CML, NHL, MDS from refinery work or recalled sunscreens, antiperspirants, and dry shampoos.
Talcum Powder
Johnson & Johnson talc claims linked to ovarian cancer and mesothelioma — MDL 2738, active in 2026.
Tepezza
Thyroid eye disease infusion claims for permanent hearing loss and tinnitus — MDL 3079.
Taxotere
Docetaxel chemotherapy claims for permanent hair loss and tear-duct eye injuries — MDL 2740/3023.
Silicosis
Engineered-stone countertop worker claims for silicosis — 560+ confirmed CA cases, early-stage litigation with plaintiff verdicts.
Paraquat
Herbicide exposure claims for Parkinson's disease — MDL 3004, ~6,600 federal plaintiffs, new claims still filed in 2026.
Paragard
Copper IUD breakage claims for surgical retrieval and related injuries — MDL 2974, ~4,000 federal cases.
Wildfire
Eaton and Palisades fire claims against Southern California Edison — SOL deadlines begin January 2027.
IVC Filter
Retrievable vena cava filter claims for fracture, migration, and perforation — Cook MDL 2570, ~6,500 cases pending and still open.
Mesothelioma
Asbestos exposure claims for mesothelioma and lung cancer — state court dockets plus 60+ bankruptcy trusts holding $30B+.
Allergan Breast Implant
Recalled BIOCELL textured implant claims for BIA-ALCL and explant surgery — MDL 2921, first bellwether October 2026.
Valsartan
NDMA-contaminated blood pressure medication claims for cancer — MDL 2875, personal injury track still in active litigation.
Exactech
Recalled knee, hip, and ankle implant claims for revision surgery — MDL 3044, currently stayed by Chapter 11 bankruptcy.
Philips CPAP
PE-PUR foam degradation claims from recalled sleep devices — MDL 3014, settlement registration closed January 2025.
Motor Vehicle Accidents
Exclusive motor vehicle accident leads — live transfers, qualified forms, and data leads with TCPA and DPPA compliance baked in.
Transvaginal Mesh (TVM)
Pelvic mesh erosion, chronic pain, and revision-surgery claims from POP and SUI implants.
Premises Liability
Slip and fall, negligent security, and dangerous-condition claims against property owners.
CA Juvenile Detention Abuse
Survivors of staff sexual abuse in California juvenile halls and probation camps, under the AB 218 revival window.
CA Women's Prison Abuse
Women sexually abused by correctional staff in California state and federal women's facilities.
How It Works
Define Criteria
We work with your team to establish exact case criteria, geographic targets, and qualification standards for your mass tort campaign.
Launch Campaign
Our multi-channel acquisition engine deploys targeted campaigns across TV, digital, social, and community outreach to reach affected populations.
Screen & Qualify
Every potential claimant is screened by our trained intake specialists against your case criteria before they ever reach your firm.
Deliver Leads
Qualified, case-ready claimants are delivered in real-time via live transfer, with full documentation and your dedicated account executive tracking performance.
Why Mass Tort Marketing Agency
Exclusive Leads
Every claimant we deliver is exclusive to your firm. We never resell leads or share claimant information with competing practices.
Proven ROI
Our clients see an average return of eight dollars for every dollar invested in mass tort lead generation campaigns with us.
Firms Served
Hundreds of personal injury and mass tort practices trust our platform to deliver qualified, case-ready claimants to their intake teams.
Mass tort leads: cost, exclusivity, and qualification
Straight answers to the questions law firms ask before buying mass tort leads.
- What is a qualified mass tort lead?
- A qualified mass tort lead is a claimant screened against a firm's specific case criteria (exposure or injury markers and state eligibility), delivered exclusively to one firm, and carrying a TrustedForm or Jornaya TCPA consent token. Mass Tort Marketing Agency meets all of these standards before delivering any lead.
- How much do mass tort leads cost?
- Mass Tort Marketing Agency prices and reports on cost per signed retainer (CPSR) rather than a flat cost per lead, so spend ties to signed cases. CPSR varies by tort, channel, and competition — see our published cost-per-signed-retainer benchmarks for tort-by-tort ranges.
- Are mass tort leads exclusive to my firm?
- Yes. Every mass tort lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are mass tort leads verified for TCPA consent?
- Each lead carries a TrustedForm or Jornaya authentication token captured with one-to-one consent naming the retaining firm, with the disclosure language, IP address, and timestamp preserved for audit.
- What is cost per signed retainer (CPSR)?
- Cost per signed retainer is total campaign spend divided by the number of claimants who sign a retainer with the firm. It is the metric Mass Tort Marketing Agency measures campaigns on, in place of cost per lead, because it ties marketing spend directly to acquired cases.
- How is a mass tort marketing agency different from a mass tort lead generation company?
- A lead generation company typically sells lead volume. A mass tort marketing agency like Mass Tort Marketing Agency runs end-to-end campaigns — strategy, compliant creative, intake, qualification, and signed-retainer reporting — and is accountable on cost per signed retainer.
- How are mass tort claimants screened before delivery?
- Trained intake specialists screen every claimant against your tort-specific case criteria — exposure windows, injury markers, prescribing or use dates, and state eligibility — before the lead reaches your firm.
- How quickly are qualified leads delivered?
- Qualified claimants can be delivered in real time via live transfer to your intake team, which maximizes conversion and reduces time-to-retainer.
Adjacent pillars: mass tort intake, mass tort lead generation, personal injury lead generation, mass tort advertising landscape. Compare providers in the top mass tort marketing firms guide, or see tort-by-tort pricing in cost per signed retainer 2026.
Keep going
Related reading
What mass tort lead generation costs
Cost per lead and cost per signed case by tort, with the budget model we use to forecast campaigns.
Mass tort marketing agency vs lead vendor
Why an agency that signs retainers beats a vendor that ships leads, with the economics side by side.
Mass tort signed retainers
Buy signed retainers instead of leads — pricing, medical-record standards, and case rejection terms.
Mass tort intake services
Intake staffing, call scripts, and retainer chase sequences that convert qualified leads into signed cases.
Mass tort marketing agency
What a mass tort marketing agency does, how engagements are structured, and what to expect in month one.
Ready to review your next mass tort campaign?
Tell us about your firm, target cases, and intake capacity. A strategist will respond in under 5 minutes during business hours with practical next steps.
Speed-to-lead is the largest single lever in intake conversion: the gap between a 5-minute and a 30-minute callback is measured in retainers lost, not opportunities lost. The same clock is running on the torts you have not claimed yet.
Built for personal injury firms, intake teams, and mass tort dockets